Диссертация (1140912), страница 21
Текст из файла (страница 21)
J.-H., S. Hsueh et al // Cancer. –1999. – N85. – P. 1537-1546.82. Lambin, P. Phase III trial comparing two low dose rates in brachytherapy ofcervix carcinoma: Report at two years / P. Lambin, A.G., A. Kramar, P. Scalliet, C.Haie-Meder, E.-P. Malaise, D. Chassagne // Int. J. Radiat. Oncol. Biol. Phys. – 1993. –N25. – 405 p.83. Landoni, F. Randomized study of radical surgery versus radiotherapy forstage Ib-IIa cervical cancer. / F. Landoni, M. A., A. Lolombo et al.
// Lancet. – 1997. –N350. – P. 535-540.84. Lawson, C. ICAM-1 signaling in endothelial cells / C. Lawson, W. S.(2009). // Pharmacol Rep. – 2009. – N61 (1). – P. 22-32.85. Lea, J.S. Stage IIB–IVB cervical adenocarcinoma: prognostic factors andsurvival / J.S. Lea, S. E., R.M. Wenham et al. // Gynecol Oncol. – 2002. – N84. – P.115-119.86. Lebedev, M.Ju. Peripheral blood lymphocytes immunophenotype and serumconcentration of soluble HLA class I in burn patients / M.Ju. Lebedev, S.A.
Vilkov,M.N. Sholkina, M.A. Krizhanova, V.V. Novikov, E.S. Vyasmina, A.Ju. Baryshnikov// Burns. – 2003. – N29(2). – P. 123-128.87. Lebedev, M.Yu. Serum levels of different forms of soluble CD38 antigen inburned patients / M.Yu. Lebedev, M.N. Sholkina, S.A. Vilkov, N.I. Egorova, V.V.Novikov, A.Ju. Baryshnikov // Burns. – 2004.
– Vol.30. – № 6. – P. 552-556.88. Lee, H.C. Lipopolysaccharide Induces CD38 Expression and Solubilizationin J774 Macrophage Cells / H.C. Lee, E. Song, C. Yoo, Y. Kwak, M. Han // Mol.Cells. – 2012. – V.34. – P. 573-576.89. Lee, С.H. Enzymatic functions and structures of CD38 and homologs / С.H.Lee // Chem Immunol. – 2000. – N75. – P. 39-59.90. Levy, A. CD38 deficiency in the tumor microenvironment attenuates gliomaprogression and modulates features of tumor-associated microglia/macrophages / A.Levy, B. E., H.
Vaknine, F.E. Lund, R. Stein, L. Mayo // Neuro Oncol. – 2012. – N14(8). – P. 1037-1049.11591. Li, Y. Matrix metalloproteinase-9 is a prognostic marker for patients withcervical cancer / Y. Li, W.T., B. Zhang, Y. Yao, G. Yin // Med Oncol. – 2012. –Jun 30.92. Liao, C.K. Endometrial cancer in Asian migrants to the United States andtheir descendants / C.K. Liao, R.K.A., S.M. Schwartz, N.S.
Weiss // Cancer CausesControl. – 2003. – N14. – P. 357-360.93. Littler, A.J. A distinct profile of six soluble adhesion molecules (ICAM1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis/ A.J. Littler, C.D. Buckley, P. Wordsworth // Br. J. Rheumatol. – 1997.
– V.36. –P. 164-169.94. Lowrey, G.C. Stage IB or IIA-B carcinoma of the intact uterine cervix treated with irradiation: A multivariate analysis / G.C. Lowrey, W. M. M., R.R. Million //Int. J. Radiat. Oncol. Biol. Phys. – 1992. – N24. – 205 p.95. M. Djerbi, The inhibitor of death receptor signaling. FLICE-inhibitory protein defines a new class of tumor progression factors / M. Djerbi, S.V., A.
Catrina A.I., B. Bogen, P. Biberfeld, A. Grandien // J. Exp. Med. – 1999. – N190. – P. 10251031.96. Malavasi, F. Evolution and Function of the ADP Ribosyl Cyclase/CD38Gene Family in Physiology and Pathology / F. Malavasi, S. Deaglio, A. Funaro et al. //J. Physiol. – 2008. – V.88. – P. 841-886.97. Martin, S. Circulating forms of ICAM-3 (cICAM-3).
Elevated levels in autoimmune diseases and lack of association with cICAM-1 / S. Martin, P. Rieckmann //J. Immunol. – 1995. – V.154. – N four. – P. 1951-1955.98. Mastroianni, C.M. Changes in circulating levels of soluble cell adhesionmolecules following highly active antiretroviral treatment of HIV-1-infected patients /C.M. Mastroianni, M. Lichtner, F.
Mengoni et al. // Clin. Immunol. – 2000. – Vol.95.– P.212-217.99. Medema, J.P. Immune escape of tumors in vivo by expression of cellularFLICE-inhibitory protein / J.P. Medema, d.J.J., van Hall T., C.J.M. Melief // J. Exp.Med. – 1999. – N190. – P. 1033-1038.116100. Mehta, A.
Association of antigen processing machinery and HLA classI defects with clinicopathological outcome in cervical carcinoma / A. Mehta, J.E.,G. Kenter, S. Ferrone, G.J. Fleuren // Cancer Immunol Immunother. – 2008. – N57.– Р. 197-206.101. Menon, A. Immune system and prognosis in colorectal cancer: a detailedimmunohistochemical analysis / A. Menon, J.-v. R.
C., H. Morreau et al. // Lab Invest.– 2004. – N84. – P. 493-501.102. Monnier-Benoit, S. Immunohistochemical analysis of CD4+ and CD8+T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix / S. Monnier-Benoit, M. F., D. Riethmuller, J.S.Guerrini, M. Capilna, S. Felix, E. Seilles, C. Mougin, J.L. Pretet // Gynecol Oncol. –2006. – N102. – P. 22-31.103. Mu, CY. High expression of PD-L1 in lung cancer may contribute topoor prognosis and tumor cells immune escape through suppressing tumor infiltratingdendritic cells maturation / CY. Mu, JA.
Huang, Y. Chen, C .Chen, XG .Zhang // MedOncol. - 2011.-28: 682-8.104. Nasu, K. Serum levels of soluble intercellular adhesion molecule-1(ICAM-1) and the expression of ICAM-1 mRNA in uterine cervical cancer / K. Nasu,N.H., Y. Etoh, Y. Kawano, Y. Hirota, I. Miyakawa // Gynecol Oncol. – 1997. – N65(2). – P.
304-308.105. Nedergaard, B.S. Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer / B.S. Nedergaard,L. M., H.F. Thomsen, J.R. Nyengaard, K. Nielsen // Br J Cancer. – 2007. – N97. – P.1135-1138.106. Nicolo, C. UVB-induced apoptosis of human dendritic cells: contributionby caspase-dependent and caspase-independent pathways / C. Nicolo, T.B., M.R.Rippo, R. Testi // Blood. – 2001.
– N97. – P. 1803-1808.107. Niitsu, N. A high serum soluble Fas/APO-1 level is associated with apoor outcome of aggressive non-Hodgkin’s lymphoma / N. Niitsu, K. Sasaki, M.Umeda // Leukemia – 1999 – Vol.13. – N9.117108. Nishibori, M. The regulation of ICAM- 1 and LFA-1 interaction by autacoids and statins: a novel strategy for controlling inflammation and immune responses/ M. Nishibori, H.
T., S. Mori // J. Pharmacol. Sci. – 2003. – N92. – P. 7–12.109. Nocito, M. Increased soluble serum HLA class I antigens in patients withlymphoma / M. Nocito, C. Montalban, P. Gonzales-Porque, LM. Villar // Hum. Immunol. – 1997. – N58 (2). – P. 106–111.110. Onda, T. Treatment of node-positive endometrial cancer with completenode dissection, chemotherapy and radiation therapy / T. Onda, H.Y., K.
Mizutani etal. // Br. J. Cancer. – 1997. – N75 – P. 1836-1841.111. Owen-Schaub, L.B.Soluble Fas and cancer / L. B. Owen-Schaub, v.G.K.L., L. L. Hill, J.E. Price // Clin Cancer Res. – 2001. – N7 (5). – P. 1108-1109.112. Owen-Schaub, L.B. Fas and Fas ligand interactions suppress melanomalung metastasis / L.B. Owen-Schaub, v. G. K. L., L. L.
Hill, J. E. Price // J. Exp. Med.– 1998. – N188. – P. 1717-1723.113. Parkin, D.M. Global Cancer Statistics / D.M. Parkin, P. P., J. Ferlay // CaCancer J. – 1999. – N49 (1). – P. 33-64.114. Partida-Sanchez, S. Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophilsand is required for bacterial clearance in vivo / S. Partida-Sanchez, C.D., S. Monard etal. // Nat Med. – 2001. – N7. 2. – P.
1209-1216.115. Partida-Sanchez, S. Regulation of dendritic cell trafficking by the ADPribosyl cyclase CD38: impact on the development of humoral immunity / S. PartidaSanchez, G. S., R. Kusser et al. // Immunity. – 2004. – N20. – P. 279-291.116. Perez, O.D. Activation of the PKB/AKT pathway by ICAM-2 / O.D. Perez, S.K., Y. Hitoshi, D.G. Payan, T.
Kitamura, G.P. Nolan, J.B. Lorens // Immunity. –2001. – N16. – P. 51–65.117. Phillips, D.H. Understanding the genotoxicity of tamoxifen? / D.H. Phillips // Carcinogenesis. – 2001. – N22. – P. 839-849.118. Piersma, S.J. High number of intraepithelial CD8+ tumor-infiltratinglymphocytes is associated with the absence of lymph node metastases in patients with118large early-stage cervical cancer / S.J.
Piersma, J.E., van Poelgeest M.I., K.M. Kwappenberg, van der Hulst J.M., J.W. Drijfhout, C.J. Melief, G.G. Kenter, G.J. Fleuren, R.Offringa, van der Burg S.H. // Cancer Res. – 2007. – N67. – P. 354-361.119. Poulsen, M.G. "The salvage of the recurrent endometrial carcinoma in thevagina and pelvis / M.G. Poulsen, S. R. // Int.
J. Radiat. Oncol. Biol. Phys. – 1988. –N15. – P. 809-813.120. Rabinovich, G.A. Immunosuppressive strategies that are mediated by tumor cells / G.A. Rabinovich, G.D., E.M. Sotomayor // Annu Rev Immunol. – 2007. –N25. – P. 267-296.121. Roland, C.L. ICAM-1 expression determines malignant potential ofcancer / C.L. Roland, H.
A., M.G. Sarr, Barnett CC Jr. // Surgery. – 2007. – N141(6). – P. 705-707.122. Sanseverino, F. PRb2/p130 and VEGF expression in endometrial carcinoma in relation to angiogenesis and histopathologic tumor grade / F. Sanseverino,R.S., M. Torricelli et al. // Cancer Biol. Ther. – 2006. – N5. – P. 84-88.123. Santin, A. Induction of tumor-specific cytotoxicity in tumor infiltratinglymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patientswith cancer of the uterine cervix / A. Santin, B.S., M. Palmieri et al. // Gynecol Oncol.– 2003. – N89. – P. 271-280.124.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
